President Trump's NIH funding cuts had threatened to derail the promising trial. A promising government-funded cancer trial is back in motion after budgetary and workforce cuts imposed by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback